AB154

Other Medications

EU Experimental ES med_spain_not_available 1 Clinical Trials

Description

AB154 is an investigational medication currently being studied in clinical trials. It is being evaluated as a potential treatment for various types of cancer, including colorectal cancer. The trials are in the early phase (Phase 1), focusing on determining the safety and tolerability of AB154, often in combination with other cancer treatments. The specific role of AB154 in colorectal cancer treatment is still under investigation. Some trials involving AB154 are specifically looking at patients whose tumors have certain genetic changes (mutations) like EGFR, KRAS, MET, NRAS, or VEGF mutations, or specific protein levels like PD-L1. This suggests researchers are exploring if AB154 might be effective for specific subgroups of colorectal cancer patients.

Mechanism of Action

The specific way AB154 works (its mechanism of action) is still being investigated in clinical trials. It is an investigational drug, meaning its precise molecular target and how it affects cancer cells are not yet fully understood or established. Researchers are studying how it interacts with cancer cells and the body to determine its potential therapeutic effects.

Side Effects

As AB154 is an investigational drug in early-phase clinical trials (Phase 1) The full range of potential side effects is still being evaluated. Information about side effects is primarily collected during these trials to assess safety and tolerability. Specific side effect data for AB154 in colorectal cancer patients is not yet widely available But as trials progress More information will become known.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT04999761 med_phase_prefix1
Recruiting
AB122 Platform Study
Japan

Quick Info

CategoryOther Medications
EU Estado EMAExperimental
ES Acceso Españamed_spain_not_available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
767 trials
Leucovorin
Other Medications
625 trials
Trifluridine
Other Medications
44 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.